• Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture

    Dec 21, 2015, 09:14 AM by Michael Croft
    Xconomy | Bayer and CRISPR Therapeutics have signed a pact that could be worth more than $335 million to develop CRISPR-based drugs for a variety of diseases starting with blindness, blood disorders, and congenital heart disease.
    Full story
  • The Personal Genome Project, Ten Years Later

    Dec 18, 2015, 13:01 PM by Michael Croft
    Techonomy | A decade ago, the Personal Genome Project became the first massive study of people sharing their full genome information. Many thought it unlikely to succeed.
    Full story
  • Juniper warns about spy code in firewalls

    Dec 18, 2015, 09:33 AM by Michael Croft
    Computerworld | Juniper, a major manufacturer of networking equipment, said on Thursday it found spying code planted in certain models of its firewalls, an alarming discovery that echoes of state-sponsored tampering.
    Full story
  • AMP, FDA Debate Regulation of Laboratory-Developed Tests

    Dec 17, 2015, 13:15 PM by Michael Croft
    Bio-IT World | The Association of Molecular Pathology (AMP) accused the Food and Drug Administration of fabricating some of the examples included in a recent FDA report outlining the public health evidence for FDA oversight of laboratory-developed tests.
    Full story
  • Congress Gives Big Funding Increase to NIH

    Dec 16, 2015, 15:40 PM by Michael Croft
    STAT | The spending bill for the federal government, still pending passage, ends more than 12 years of stagnant budgets for NIH with a $2 billion raise.
    Full story
  • Long-Read Sequencing in the Age of Genomic Medicine

    Dec 16, 2015, 13:45 PM by Michael Croft
    Diagnostics World | Long-read sequencing today is mostly a curiosity of basic research, but Roche Diagnostics is now planning to commercialize it for clinical testing with a high-throughput instrument launch in 2016. Robert Sebra, Director of Technology Development at Mount Sinai, tells us where he sees the most promise in using long-read sequencing to diagnose and treat patients.
    Full story
  • Sinequa Selected by UCB to Reduce Time and Cost of Searching Clinical Trial Data

    Dec 16, 2015, 13:31 PM by Michael Croft
    NEW YORK, NY - Dec 16, 2015 -  Sinequa, a leader in real-time Big Data search and analytics, today announced that UCB has selected the Sinequa Big Data Search & Analytics Platform to speed vital information discovery of its clinical trial file share
    Full story
  • FDA Brings PrecisionFDA Platform Online

    Dec 15, 2015, 10:45 AM by Michael Croft
    Bio-IT World News Brief | This morning, the FDA announced the availability of precisionFDA, a platform where developers can upload and access pipelines for the analysis of next-generation sequencing data, comparing results against best-in-class reference standards.
    Full story
  • Strategic Partnership Attracts Plant Genomics Expert to Region

    Dec 15, 2015, 10:40 AM by Michael Croft
    ST. LOUIS, MO, UNITED STATES - Dec 15, 2015 - Officials from the Donald Danforth Plant Science Center in St. Louis and the University of Missouri (MU) announced today the joint hiring of Blake Meyers, Ph
    Full story
  • Personalized Medicine: A Faustian Bargain?

    Dec 14, 2015, 16:12 PM by Michael Croft
    Scientific American Blog Network | Two specialists in the ethics and policy of biotechnology argue that personalized medicine is in danger of denying state-of-the-art care to the very data donors who make new discoveries possible.
    Full story
  • AstraZeneca Joins a $100M Research Effort to Investigate the 'Secretome'

    Dec 11, 2015, 11:29 AM by Michael Croft
    FierceBiotech | AstraZeneca, on the hunt for new drug targets and delivery mechanisms, is teaming up with the Swedish Wallenberg Centre for Protein Research to explore the universe of proteins secreted by human cells.
    Full story
  • Computer Science Project Evolves Into New Tool for the Biotech Industry

    Dec 11, 2015, 10:20 AM by Michael Croft
    RALEIGH, NC - Dec 11, 2015 - When Scott Vu started working on a computer science research project as a teenager, he didn’t realize it would lead to his launching a company designed to help the biotechnology industry operate more efficiently
    Full story
  • Rubius Snags $25M to Engineer Red Blood Cells Into Drugs

    Dec 10, 2015, 12:07 PM by Michael Croft
    Forbes | Flagship Ventures-funded Rubius Therapeutics wants to insert genes for therapeutic enzymes into blood-forming stem cells, then infuse the nucleus-free mature cells into patients to fight disease.
    Full story
  • CRISPR Design Company Desktop Genetics Gets Boost from Illumina

    Dec 10, 2015, 11:20 AM by Michael Croft
    Bio-IT World News Brief | Illumina has made an investment in Desktop Genetics, a company that provides software for the design of CRISPR-Cas9 gene editing complexes.
    Full story
  • sbv IMPROVER Launches Fourth Systems Toxicology Challenge

    Dec 10, 2015, 09:00 AM by Michael Croft
    Bio-IT World Brief | sbv IMPROVER, an international scientific crowdsourcing initiative, has launched the Systems Toxicology Computational Challenge. The challenge, which is open to anyone working in computational science who is developing predictive modelling techniques, provides the unique opportunity for participants to vigorously and objectively test their methodologies. Working on blood gene expression data, participants are being challenged to derive a predictive model to distinguish current smokers from either non-smokers or former-smokers. Entries will be scored by an independent panel against a gold-standard dataset.
    Full story
  • Silicon Mechanics Opens Education Cluster Grant Program

    Dec 9, 2015, 15:40 PM by Michael Croft
    Bio-IT World | Silicon Mechanics has opened its 5th Annual Research Cluster Grant (RCG) program. Two institutions will be selected, and both will be awarded a complete high-performance computing (HPC) cluster. The competition is open to all United States and Canadian qualified post-secondary institutions, university-affiliated research institutions, non-profit research institutions, and researchers at federal labs with university affiliations.
    Full story
  • Citizen Sequencers: Taking Oxford Nanopore's MinION to the Classroom and Beyond

    Dec 9, 2015, 14:10 PM by Michael Croft
    Bio-IT World | With its cheap, handheld MinION sequencers, Oxford Nanopore is looking to early adopters like Karen James to help them reach teachers and citizen scientists ready to bring DNA sequencing outside the research lab.
    Full story
  • GNS Healthcare Announces $10M Financing, MMRF Study Results

    Dec 8, 2015, 17:15 PM by Michael Croft

    Bio-IT World | GNS Healthcare announced a $10M Series C financing round today. Earlier this week, the Multiple Myeloma Research Foundation (MMRF) announced preliminary results of a multi-year collaboration with GNS to speed the discovery of innovative treatments for patients with multiple myeloma. 

    Full story
  • DIAGNOMICS AND MAVERIX ACHIEVE CLIA VALIDATION FOR CLINICAL DIAGNOSTIC PRE-NATAL TESTING

    Dec 8, 2015, 10:36 AM by Michael Croft
    SAN MATEO, CA - Dec 8, 2015 - Maverix Biomics, Inc., a leading genomic analysis software company, and Diagnomics, a developer of innovative products and services for personalized medicine based on Next Generation Sequencing (NGS) technology, today announced their achievement of Clinical Laboratory Improvement Amendments (CLIA) validation for NGS based Pre-natal Testing using the Maverix Dx Platform
    Full story
  • Googles Life Sciences division is now called Verily

    Dec 8, 2015, 09:10 AM by Michael Croft
    Computerworld | Google's parent company, Alphabet, has renamed its life sciences division Verily and given it the goal to "understand disease at the individual level."
    Full story